Dermatological aspects of male hypogonadism

被引:0
|
作者
Köhn, FM
Ring, J
Schill, WB
机构
[1] Tech Univ Munich, Klin & Poliklin Dermatol & Allergol, D-80802 Munich, Germany
[2] Univ Giessen, Zentrum Dermatol & Androl, Giessen, Germany
来源
HAUTARZT | 2000年 / 51卷 / 04期
关键词
hypogonadism; androgens; testosterone; gonadotropins; skin lesions;
D O I
10.1007/s001050051025
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Since the skin and its appendages are androgen-dependent, male hypogonadism can be associated with dermatologically relevent lesions. The skin surface of hypogonadal patients is thin and shows increased wrinkles. In cases of prepubertal hypogonadism, severe acne does not occur. In contrast, patients may suffer from sebostasis due to missing stimulation of the sebaceous glands. The genital skin does not show pigmentation,which normaly develops during puberty; the integument is pale. Hair growth on breast, pubia, axilla, face and integument is reduced; patients do not present with typical androgenetic alopecia. In addition to these features, dermatological diseases caused by treatment of the hypogonadism or drug-induced skin reactions have to be considered. While drug reactions to oral or intramuscular androgens or gonadotropins are rare, irritative or allergic skin lesions are observed frequently, especially in cases of non-scrotal transdermal therapeutic systems with testosterone. A variety of syndromes include dermatological symptoms associated with male hypogonadism; however, the prevalence of these syndromes is low.
引用
收藏
页码:223 / 230
页数:8
相关论文
共 50 条
  • [1] Dermatological aspects of male hypogonadism [Dermatologische aspekte des mannlichen hypogonadismus]
    Köhn F.-M.
    Ring J.
    Schill W.-B.
    Der Hautarzt, 2000, 51 (4): : 223 - 230
  • [2] Clinical and hormonal aspects of male hypogonadism in myotonic dystrophy
    Mastrogiacomo, I
    Bonanni, G
    Menegazzo, E
    Santarossa, C
    Pagani, E
    Gennarelli, M
    Angelini, C
    ITALIAN JOURNAL OF NEUROLOGICAL SCIENCES, 1996, 17 (01): : 59 - 65
  • [3] The "obese" and "old" male patient in dermatological practice When should hypogonadism be considered?
    Varwig-Janssen, D.
    Ochsendorf, F.
    HAUTARZT, 2015, 66 (12): : 898 - 906
  • [4] Subclinical male hypogonadism
    Corona, Giovanni
    Rastrelli, Giulia
    Dicuio, Mauro
    Concetti, Sergio
    Minnetti, Marianna
    Pivonello, Rosario
    Isidori, Andrea
    Sforza, Alessandra
    Maggi, Mario
    MINERVA ENDOCRINOLOGY, 2021, 46 (03): : 252 - 261
  • [5] Subclinical male hypogonadism
    Giannetta, Elisa
    Gianfrilli, Daniele
    Barbagallo, Federica
    Isidori, Andrea M.
    Lenzi, Andrea
    BEST PRACTICE & RESEARCH CLINICAL ENDOCRINOLOGY & METABOLISM, 2012, 26 (04) : 539 - 550
  • [6] Therapy of male hypogonadism
    Zitzmann, M.
    INTERNIST, 2008, 49 (05): : 559 - +
  • [7] Male hypogonadism and infertility
    Zitzmann, Michael
    GYNAKOLOGISCHE ENDOKRINOLOGIE, 2019, 17 (04): : 230 - 235
  • [8] Cardiovascular disease and testosterone therapy in male hypogonadism
    de Silva, Nipun Lakshitha
    Grant, Bonnie
    Minhas, Suks
    Jayasena, Channa N.
    ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 2024, 1540 (01) : 121 - 132
  • [9] Hypogonadism in male and female: which is the best treatment?
    Bertelli, Enrica
    Di Frenna, Marianna
    Cappa, Marco
    Salerno, Mariacarolina
    Wasniewska, Malgorzata
    Bizzarri, Carla
    De Sanctis, Luisa
    MINERVA PEDIATRICS, 2021, 73 (06): : 572 - 587
  • [10] Male hypogonadism. Part I: Epidemiology of hypogonadism
    A D Seftel
    International Journal of Impotence Research, 2006, 18 : 115 - 120